Aspire BioPharma, Inc. (ASBP) — Cash Flow Reinvestment Rate
Latest as of December 2024:
0.00x
Aspire BioPharma, Inc. (ASBP) has a Cash Flow Reinvestment Rate of 0.00x as of December 2024, reinvesting $4.00 (capex $4.00 ) from operating cash flow of $479.57K. See ASBP free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
0.00x
(Capex + Investments) / Operating CF
Total Reinvested
$4.00
Capex + Investments
Operating Cash Flow
$479.57K
USD
Capital Expenditures
$4.00
USD
Annual Cash Flow Reinvestment Rate for Aspire BioPharma, Inc. (None–None)
Year-by-year capital reinvestment analysis for Aspire BioPharma, Inc.. See ASBP financial flexibility index to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow